两资产挂牌无人问津就再打折！永和智控“割肉求生”

Group 1 - The company announced the public transfer of 100% equity of its wholly-owned subsidiary, Kunming Medical Oncology Hospital, with an initial listing price of 35.93 million yuan, which was later reduced by 20% to 28.74 million yuan due to lack of interest from potential buyers [1] - The company also attempted to transfer 51% equity of its subsidiary, Puluo New Energy Technology (Taixing) Co., Ltd., with an initial price of 30.49 million yuan, which was subsequently reduced to 24.39 million yuan and then to 18.29 million yuan, ultimately reaching a fourth listing price of 12.20 million yuan after three unsuccessful attempts [2] - The company has been facing financial difficulties, reporting net losses of 26.19 million yuan, 156 million yuan, and 297 million yuan from 2022 to 2024, indicating a trend of "cutting losses to survive" [2] Group 2 - For the first three quarters of 2025, the company reported a revenue of 582 million yuan, a year-on-year decrease of 7.2%, while the net loss narrowed from 76.20 million yuan to 60.46 million yuan [3] - In the third quarter, the company achieved a revenue of 215 million yuan, a year-on-year increase of 4.3%, but the net loss widened from 19.96 million yuan to 22.84 million yuan [3] - The company's operating cash flow showed a significant improvement, with a net cash flow of 47.89 million yuan, representing a year-on-year increase of 162.6% [3]